Chargement en cours...
Overcoming Platinum and PARP-Inhibitor Resistance in Ovarian Cancer
Platinum chemotherapy remains the cornerstone of treatment for epithelial ovarian cancer (OC) and Poly (ADP-ribose) polymerase inhibitors (PARPi) now have an established role as maintenance therapy. The mechanisms of action of these agents is, in many ways, complementary, and crucially reliant on th...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
MDPI AG
2020-06-01
|
| Collection: | Cancers |
| Sujets: | |
| Accès en ligne: | https://www.mdpi.com/2072-6694/12/6/1607 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|